Appealing a GLP-1 insurance denial is a real process with real steps, not just a formality you go through before giving up. It also is not your only path, since a cash-pay compounded option exists entirely outside it.
Read the denial letter, gather documentation, and file within your plan's deadline. While you do, telos rx offers compounded GLP-1 medication through an asynchronous intake reviewed by a licensed provider, with no insurance process required at all.
Start your intake →Step one: understand the denial
Read your denial letter carefully. It should state the specific reason for the denial, whether that is a formulary exclusion, a failed prior authorization, a step therapy requirement, or a medical necessity determination.
If the letter is vague, call your plan's member services line and ask for the specific reason in writing. You need something concrete to respond to, not a general summary given over the phone.
Different denial reasons call for different appeal strategies. A documentation gap needs a resubmission. A substantive medical necessity denial needs a detailed letter addressing the plan's own criteria directly.
A formulary exclusion is different still. It usually cannot be fixed through documentation alone, since the medication simply is not on the plan's covered drug list regardless of your specific case.
Note the deadline for filing an internal appeal, which is printed on the letter itself. Most plans give a window measured in months, but missing it can close off that particular route entirely.
Write down the date you received the denial letter, since some deadlines are calculated from that date rather than the date printed on the letter itself. A few days of difference can matter.
If you are unsure which category your denial falls into, call your plan and ask them to categorize it clearly. The category determines which documents and arguments will actually be relevant to your appeal.
Step two: gather your documentation
Collect your relevant labs, prior treatment records, and any notes from your prescribing provider explaining why GLP-1 therapy was recommended for you in the first place.
Ask your provider for a detailed letter of medical necessity. It should address the plan's specific stated reason for the denial directly, rather than offering only general support for the prescription.
If your plan requires step therapy, gather evidence of any earlier treatments you already tried, including dates, outcomes, and any side effects that made them inappropriate for continued use.
If you are appealing a formulary exclusion rather than a documentation gap, ask your provider whether a formal exception request is even available under your plan. Confirm that before investing significant time in an appeal.
Organize everything before you start writing the appeal itself. A well-organized file moves faster through review than one assembled piecemeal as questions come up along the way.
Request a copy of your plan's specific coverage policy for GLP-1 medications, if you have not already. It lists exactly what your documentation needs to demonstrate, which removes much of the guesswork.
Ask your provider's office how they typically structure an appeal letter for this kind of denial. An office that handles GLP-1 appeals regularly often has a template that addresses common plan requirements efficiently.
Read your appeal letter fully before it is submitted, even if your provider's office drafted most of it. You know your own history best, and catching a small error early on saves real time later.
While you gather these documents, some people also start a cash-pay intake in parallel, so treatment is not entirely dependent on how the appeal turns out.
Step three: consider a peer-to-peer review
Ask your provider's office whether they will request a peer-to-peer review. This is a direct conversation between your physician and the plan's reviewing clinician about your specific case.
Peer-to-peer reviews resolve some denials without ever reaching a formal written appeal, since your physician can address the reviewer's specific concerns in real time rather than through paperwork alone.
Not every practice requests these reviews proactively. If your provider's office has not mentioned it, ask directly whether it is an option for your specific denial.
During the call, your physician can bring up details from your chart that a written appeal might not fully capture, like the tone and trajectory of a longer clinical relationship with you.
A peer-to-peer review does not guarantee approval, but it is often faster than the full internal appeal process and worth exploring before committing to the longer route.
If your provider's office is hesitant to request one, ask why. Sometimes it is a scheduling constraint that can be resolved, and other times it reflects a genuine judgment that the review would not help your case.
Step four: file the formal appeal
Submit your internal appeal within the plan's stated deadline, including your letter of medical necessity and all supporting documentation you have gathered.
Keep copies of everything you submit, along with the date and method of submission. If your plan claims something was never received, your own records let you respond with specifics.
Follow up if you do not hear back within the timeframe your plan states for a decision. Plans are generally required to respond within a defined window, though it varies by state and plan type.
Document each follow-up call, including the date, the representative you spoke with, and what they told you about your appeal's status. This record becomes useful if the process drags on longer than expected.
If the internal appeal is denied, ask specifically about your right to an external review. Many states require insurers to offer this as an independent check on their own internal decision.
Some plans allow an expedited appeal in urgent situations, with a much shorter turnaround than the standard process. Ask your provider whether your situation qualifies for that faster track.
Key takeaway: An appeal has real steps and real deadlines. Follow them carefully, and consider a cash-pay compounded path in parallel rather than waiting on the outcome alone.
Step five: pursue external review if needed
An external review is conducted by an independent party outside your insurance company. Plans do not have unchecked final authority over every medical coverage decision under most state insurance laws.
This step typically has its own deadline, separate from the internal appeal deadline, so check your plan's documentation for the specific window that applies once an internal appeal is denied.
External review decisions are often binding on the insurer, which makes this step meaningful even after an internal appeal has already failed to produce the outcome you wanted.
The independent reviewer looks at your full file fresh, without deferring automatically to the insurer's original conclusion, which is exactly why this step can change the outcome even after two prior denials.
Not every state requires this option for every type of plan, and self-funded employer plans sometimes follow noticeably different rules than fully insured commercial plans do.
Ask your plan directly whether external review applies to your specific situation, since the answer depends on your state and the type of plan your employer offers.
Your state's department of insurance is a useful resource if your plan is unclear or unresponsive about your external review rights. They can often clarify what your specific state requires.
Self-funded employer plans are regulated differently than fully insured plans, so a state regulator's authority may be more limited in those cases. Your plan's summary documents will indicate which type applies to you.
A cash-pay path that does not depend on any of this
telos rx offers compounded semaglutide and compounded tirzepatide. Both are evaluated through an asynchronous intake with a licensed provider, entirely outside the insurance appeals process.
This is not insurance-covered, and Medicare, Medicaid, and commercial plans do not pay for compounded medication regardless of how your appeal is eventually resolved. It is a distinct, cash-pay alternative to a branded prescription.
Approval is a genuine medical decision made by a licensed provider based on your full history. It is not automatic for anyone who applies, and it is not tied to any insurance denial you may have already received.
Pricing starts as low as $99 a month, and most telos rx plans qualify for FSA or HSA funds if you have access to either account. Microdosed and oral options are available too, through microdosed tirzepatide and the oral GLP-1 program.
Shipping is included, and orders typically arrive within a couple of days once a provider approves your plan. That speed matters a great deal if an insurance appeal has already delayed things longer than you hoped.
You can start your intake here at any stage of your appeal, whether you are just beginning the process or have already exhausted every available step in it.
Frequently Asked Questions
How long does the entire appeal process usually take?
An internal appeal alone can take several weeks. If an external review becomes necessary afterward, the full process can extend to a couple of months depending on your plan and state.
Do I need a lawyer to appeal an insurance denial?
No. Most people appeal successfully without legal help, using documentation from their provider. A lawyer is rarely necessary for a standard GLP-1 coverage appeal.
Can I start a cash-pay intake while my appeal is still pending?
Yes. A telos rx intake is independent of your insurance appeal process. Starting one does not affect your right to keep pursuing the appeal.
What happens if my appeal is ultimately denied?
You can pursue external review in many states, or explore a cash-pay compounded option that does not depend on insurance approval at all.
Is compounded GLP-1 medication covered by insurance after a successful appeal?
No. Compounded medication is never covered by insurance, Medicare, or Medicaid, regardless of how any appeal for a branded prescription resolves.
What if my provider does not approve my telos rx intake?
You pay nothing if declined. Approval depends on your individual health history, and a provider may explain why the medication does not fit your specific situation.
telos rx is LegitScript-certified. Compounded semaglutide and tirzepatide are not FDA-approved, and they are prepared by partner compounding pharmacies in the United States. This article is general information, not medical advice, and does not replace guidance from your own provider or insurer. Care is subject to medical approval by a licensed provider, and approval is not automatic. telos rx operates as an online-first, asynchronous telehealth service, and compounded medication is not covered by insurance, Medicare, or Medicaid.
For background on prescription medications used for weight management, see the NIH overview of weight-loss medications. For how compounded drugs are regulated in the United States, see the FDA overview of drug compounding.
Ready to explore a cash-pay option? Begin your GLP-1 intake or learn more on the telos rx semaglutide page.